AU5913098A - Opiate antagonist implant and process of preparation therefor - Google Patents

Opiate antagonist implant and process of preparation therefor

Info

Publication number
AU5913098A
AU5913098A AU59130/98A AU5913098A AU5913098A AU 5913098 A AU5913098 A AU 5913098A AU 59130/98 A AU59130/98 A AU 59130/98A AU 5913098 A AU5913098 A AU 5913098A AU 5913098 A AU5913098 A AU 5913098A
Authority
AU
Australia
Prior art keywords
opiate antagonist
preparation therefor
implant
antagonist implant
therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59130/98A
Inventor
Lance L. Gooberman
George J. Malmberg
Alan R. Tripp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU5913098A publication Critical patent/AU5913098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU59130/98A 1997-01-13 1998-01-13 Opiate antagonist implant and process of preparation therefor Abandoned AU5913098A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2860597P 1997-01-13 1997-01-13
US60028605 1997-01-13
US82900397A 1997-03-31 1997-03-31
US08829003 1997-03-31
PCT/US1998/000510 WO1998030171A1 (en) 1997-01-13 1998-01-13 Opiate antagonist implant and process of preparation therefor

Publications (1)

Publication Number Publication Date
AU5913098A true AU5913098A (en) 1998-08-03

Family

ID=26703898

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59130/98A Abandoned AU5913098A (en) 1997-01-13 1998-01-13 Opiate antagonist implant and process of preparation therefor

Country Status (3)

Country Link
AU (1) AU5913098A (en)
CA (1) CA2278137A1 (en)
WO (1) WO1998030171A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210059943A1 (en) * 2019-09-04 2021-03-04 Buffalo Pacific LLC Systems and methods addressing multiple aspects to provide a comprehensive recovery program for addictions, chronic conditions and diseases
BR102020025389A2 (en) * 2020-12-11 2022-06-21 Edson Luiz Peracchi Long-term resorbable subcutaneous implant with sustained release of pre-concentrated, polymer-concentrated pharmacologically active substance for the treatment of nicotine addiction and process
US11197819B1 (en) 2021-04-09 2021-12-14 Drug Delivery Company, Llc Extended release bioabsorbable subcutaneous medicinal dosage delivery implant system
AU2022202053A1 (en) * 2021-09-17 2023-04-06 Biocorrx, Inc. Biodegradable implant including naltrexone
WO2023164438A1 (en) * 2022-02-22 2023-08-31 Delpor, Inc. Implantable devices for the sustained delivery of an opioid antagonist and methods for treating inflammatory, neuroinflammatory and metabolic disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4351337A (en) * 1973-05-17 1982-09-28 Arthur D. Little, Inc. Biodegradable, implantable drug delivery device, and process for preparing and using the same
GB8728294D0 (en) * 1987-12-03 1988-01-06 Reckitt & Colmann Prod Ltd Treatment compositions

Also Published As

Publication number Publication date
CA2278137A1 (en) 1998-07-16
WO1998030171A1 (en) 1998-07-16

Similar Documents

Publication Publication Date Title
AU6555198A (en) Implanted structures and methods of formation
AU7710198A (en) Single pass lead and method of use
AU9028798A (en) Method of improving drug treatment
AP2000001783A0 (en) Disinfectant and method of making
AU8007000A (en) Integrated forms and method of making such forms
AU6079598A (en) Additive preparation and method of use thereof
AU6117000A (en) Novel polynucleotides and method of use thereof
GB9713703D0 (en) Preparation of opiates
AU5549896A (en) 3-substituted piperidines promote release of growth hormone
AU5978098A (en) Luminescent compounds and methods of making and using same
EP1033994A4 (en) Methods of preparation of bioginkgo
AU3068699A (en) Skin equivalent and methods of forming and using same
AU2542397A (en) Method of preparing electrodes
GB9710800D0 (en) Pharmaceutical composition and method of preparing it
AU9682098A (en) Method of building and maintaining bone
SG77180A1 (en) Preparation process of polymer
AU7290898A (en) Preparation of fagopyritols and uses therefor
HUP0003958A3 (en) Process for preparation of 4-aryl-piperidines and intermediates
PL319451A1 (en) Method of obtaining titanium oxide
AU5913098A (en) Opiate antagonist implant and process of preparation therefor
AU1812601A (en) Cover member and method of making same
ZA985147B (en) Method of making endmills
AU8817398A (en) Method of drug selection
AU8102498A (en) Preparation of diaryl-benzopyrans
AU1459500A (en) Dihydropyridine compounds and methods of use